Liu Rongfang, Nahon Dennis, le Roy Beau, Lenselink Eelke B, IJzerman Adriaan P
Division of Medicinal Chemistry, Leiden Academic Centre for Drug Research, Leiden University, P.O. Box 9502, 2300 RA Leiden, The Netherlands.
Division of Medicinal Chemistry, Leiden Academic Centre for Drug Research, Leiden University, P.O. Box 9502, 2300 RA Leiden, The Netherlands.
Biochem Pharmacol. 2015 Jun 15;95(4):290-300. doi: 10.1016/j.bcp.2015.04.005. Epub 2015 Apr 18.
The adenosine receptor subfamily includes four subtypes: the A1, A2A, A2B and A3 receptors, which all belong to the superfamily of G protein-coupled receptors (GPCRs). The adenosine A2B receptor is the least investigated of the adenosine receptors, and the molecular mechanisms of its activation have hardly been explored. We used a single-GPCR-one-G protein yeast screening method in combination with mutagenesis studies, molecular modeling and bio-informatics to investigate the importance of the different amino acid residues of the NPxxY(x)6F motif and helix 8 in the human adenosine A2B receptor (hA2BR) activation. A scanning mutagenesis protocol was employed, yielding 11 single mutations and one double mutation of the NPxxY(x)6F motif and 16 single mutations of helix 8. The amino acid residues P287(7.50), Y290(7.53), R293(7.56) and I304(8.57) were found to be essential, since mutation of these amino acid residues to alanine led to a complete loss of function. Western blot analysis showed that mutant receptor R293(7.56)A was not expressed, whereas the other proteins were. Amino acid residues that are also important in receptor activation are: N286(7.49), V289(7.52), Y292(7.55), N294(8.47), F297(8.50), R298(8.51), H302(8.55) and R307(8.60). The mutation Y290(7.53)F lost 50% of efficacy, while F297(8.50)A behaved similar to wild type receptor. The double mutation, Y290(7.53)F/F297(8.50)Y, lost around 70% of efficacy and displayed a lower potency for the reference agonist 5'-(N-ethylcarboxamido)adenosine (NECA). This study provides new insight into the molecular interplay and impact of TM7 and helix 8 for hA2B receptor activation, which may be extrapolated to other adenosine receptors and possibly to other GPCRs.
A1、A2A、A2B和A3受体,它们均属于G蛋白偶联受体(GPCR)超家族。腺苷A2B受体是腺苷受体中研究最少的,其激活的分子机制几乎未被探索。我们采用单GPCR-单G蛋白酵母筛选方法,结合诱变研究、分子建模和生物信息学,来研究人腺苷A2B受体(hA2BR)激活过程中NPxxY(x)6F模体和螺旋8不同氨基酸残基的重要性。采用扫描诱变方案,对NPxxY(x)6F模体产生了11个单突变和1个双突变,对螺旋8产生了16个单突变。发现氨基酸残基P287(7.50)、Y290(7.53)、R293(7.56)和I304(8.57)至关重要,因为将这些氨基酸残基突变为丙氨酸会导致功能完全丧失。蛋白质印迹分析表明,突变受体R293(7.56)A未表达,而其他蛋白质表达了。在受体激活中也很重要的氨基酸残基有:N286(7.49)、V289(7.52)、Y292(7.55)、N294(8.47)、F297(8.50)、R298(8.51)、H302(8.55)和R307(8.60)。突变Y290(7.53)F丧失了50%的效能,而F297(8.50)A的表现与野生型受体相似。双突变Y290(7.53)F/F297(8.50)Y丧失了约70%的效能,对参考激动剂5'-(N-乙基甲酰胺基)腺苷(NECA)的效力较低。本研究为TM7和螺旋8对hA2B受体激活的分子相互作用和影响提供了新的见解,这可能外推到其他腺苷受体,也可能推广到其他GPCR。